256 related articles for article (PubMed ID: 24594195)
1. Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action.
Bedogni F; Rossi RL; Galli F; Cobolli Gigli C; Gandaglia A; Kilstrup-Nielsen C; Landsberger N
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():187-201. PubMed ID: 24594195
[TBL] [Abstract][Full Text] [Related]
2. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
3. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
5. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
[TBL] [Abstract][Full Text] [Related]
6. Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges.
Vidal S; Xiol C; Pascual-Alonso A; O'Callaghan M; Pineda M; Armstrong J
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31409060
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Studies in Mouse Models of Rett Syndrome: A Review.
Sanfeliu A; Kaufmann WE; Gill M; Guasoni P; Tropea D
Neuroscience; 2019 Aug; 413():183-205. PubMed ID: 31229631
[TBL] [Abstract][Full Text] [Related]
8. Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.
Ehrhart F; Coort SL; Cirillo E; Smeets E; Evelo CT; Curfs LM
Orphanet J Rare Dis; 2016 Nov; 11(1):158. PubMed ID: 27884167
[TBL] [Abstract][Full Text] [Related]
9. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
10. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
11. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
12. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
13. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
14. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
15. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.
Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253
[TBL] [Abstract][Full Text] [Related]
17. Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes.
Kerr B; Soto C J; Saez M; Abrams A; Walz K; Young JI
Eur J Hum Genet; 2012 Jan; 20(1):69-76. PubMed ID: 21829232
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome.
Brown K; Selfridge J; Lagger S; Connelly J; De Sousa D; Kerr A; Webb S; Guy J; Merusi C; Koerner MV; Bird A
Hum Mol Genet; 2016 Feb; 25(3):558-70. PubMed ID: 26647311
[TBL] [Abstract][Full Text] [Related]
19. RettBASE: Rett syndrome database update.
Krishnaraj R; Ho G; Christodoulou J
Hum Mutat; 2017 Aug; 38(8):922-931. PubMed ID: 28544139
[TBL] [Abstract][Full Text] [Related]
20. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
